‘Will consider US manufacturing if there’s strategic value’
NEW DELHI: Torrent Pharma, flagship of the Ahmedabad based Torrent Group, plans to drive growth by focusing on innovation to address “unmet needs in chronic therapies” and by expanding into highgrowth segments. The company, which holds market leadership in the vitamins category with its Rs 500-crore brand Shelcal (plus variants), and has cardiac drug Nikoran…

